专题:Psychedelics and Drug Studies

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.
最新文献
A New Generation of Psychedelic-Assisted Psychotherapy: The Example of Combining MDMA With Trauma-Focused Cognitive-Behavioral Therapy for Posttraumatic Stress Disorder

article Full Text OpenAlex

Psychedelic Policy, Religious Freedom, and Public Safety: An Overview

article Full Text OpenAlex

The effect of psychedelic microdosing on animal behavior: a review with recommendations for the field

review Full Text OpenAlex

Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression

article Full Text OpenAlex

Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences

article Full Text OpenAlex

Living in the Mycelial World

article Full Text OpenAlex

Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises

article Full Text OpenAlex

5-HT2A Receptors: Pharmacology and Functional Selectivity

review Full Text OpenAlex

Psychedelic control of neuroimmune interactions governing fear

article Full Text OpenAlex

Historians on Drugs: Toward an Empirical Historiography of Global Psychedelic Cultures

article Full Text OpenAlex

近5年高被引文献
Trial of Psilocybin versus Escitalopram for Depression

article Full Text OpenAlex 1043 FWCI133.767

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

article Full Text OpenAlex 712 FWCI91.29

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

article Full Text OpenAlex 699 FWCI156.455

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

letter Full Text OpenAlex 449 FWCI0

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

article Full Text OpenAlex 391 FWCI48.093

Novel and emerging treatments for major depression

review Full Text OpenAlex 342 FWCI19.331

Increased global integration in the brain after psilocybin therapy for depression

article Full Text OpenAlex 333 FWCI73.977

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

article Full Text OpenAlex 311 FWCI69.842

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

article Full Text OpenAlex 282 FWCI34.558

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

article Full Text OpenAlex 275 FWCI126.111